ストックスクリーナーアプリを入手
13.66
2.29%
-0.32
Rocket Pharmaceuticals Inc (RCKT) 最新ニュース
Rocket Pharma Stock Slips Despite New Long-Term Data On Phase-I Study; Retail Sentiment Slides - Asianet Newsable
Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 52-Week LowHere's What Happened - MarketBeat
Rocket Pharma's Danon Disease Treatment Shows 5-Year Success in Phase 1 Trial | RCKT Stock News - StockTitan
Rocket Pharmaceuticals is Now Oversold (RCKT) - Nasdaq
When (RCKT) Moves Investors should Listen - Stock Traders Daily
Chardan Capital Has Strong Estimate for RCKT FY2024 Earnings - MarketBeat
RCKT stock touches 52-week low at $15.96 amid market challenges - Investing.com India
Rocket Pharmaceuticals' SWOT analysis: gene therapy stock faces pivotal year - Investing.com
Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions - Yahoo Finance
Rocket Pharmaceuticals' Q3 Earnings Beat, Pipeline In Focus - Barchart
Rocket Pharmaceuticals' Q3 Earnings Beat, Pipeline in Focus - Yahoo Finance
Privium Fund Management B.V. Has $5.45 Million Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Analysts Set Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Price Target at $51.75 - MarketBeat
Wellington Management Group LLP's Strategic Acquisition in Rocke - GuruFocus.com
Rocket Pharmaceuticals to Participate in the UBS Global Healthcare Conference - BioSpace
Rocket Pharmaceuticals' (RCKT) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Rocket Pharmaceuticals: Q3 Earnings Snapshot - Houston Chronicle
Rocket Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Progress - Yahoo Finance
Investors Appear Satisfied With Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Prospects As Shares Rocket 41% - Simply Wall St
Here's Why We're Watching Rocket Pharmaceuticals' (NASDAQ:RCKT) Cash Burn Situation - Yahoo Finance
Harbor Capital Advisors Inc. Has $3.11 Million Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals executive sells $51,205 in common stock - Investing.com
Rocket Pharmaceuticals executive sells $51,205 in common stock By Investing.com - Investing.com UK
Long Term Trading Analysis for (RCKT) - Stock Traders Daily
(RCKT) Trading Report - Stock Traders Daily
Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ - GlobeNewswire
Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.
Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - India Shorts
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 5.3%Here's What Happened - MarketBeat
Fanconi Anemia Pipeline Forecast 2024: FDA Approvals, Therapies, and Leading Companies | Foresee Pharma, Rocket Pharma, John Diaz, Novartis, Sierra Oncology - The Globe and Mail
Scotiabank Initiates Coverage of Rocket Pharmaceuticals (RCKT) with Sector Outperform Recommendation - MSN
Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap UpWhat's Next? - MarketBeat
Investors in cash trouble should check out Rocket Pharmaceuticals Inc (RCKT) - SETE News
Rocket Pharmaceuticals (NASDAQ:RCKT) Now Covered by Analysts at Scotiabank - MarketBeat
The Attractiveness of Investing In Rocket Pharmaceuticals Inc (RCKT) is Growing - Knox Daily
Rocket Pharmaceuticals Inc (RCKT)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Recent Insider Activity Could Benefit Pacific Biosciences of California Inc (PACB) - Knox Daily
Verisk Analytics Inc [VRSK] Investment Appeal on the Rise - Knox Daily
Rocket Pharmaceuticals Inc (RCKT)’s stock chart: A technical perspective - US Post News
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives $52.00 Consensus Target Price from Brokerages - MarketBeat
Trading (RCKT) With Integrated Risk Controls - Stock Traders Daily
Rocket Pharmaceuticals Inc (RCKT) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle
Rocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 3.8%Here's What Happened - MarketBeat
Rocket Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Rocket Pharmaceuticals Inc (RCKT) stock analysis: A comprehensive overview - US Post News
Ratio Review: Analyzing Rocket Pharmaceuticals Inc (RCKT)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
It makes sense and dollars to buy Rocket Pharmaceuticals Inc (RCKT) stock - SETE News
Rocket Pharmaceuticals Inc [NASDAQ: RCKT] Sees Decrease in Stock Value - Knox Daily
Dimensional Fund Advisors LP Trims Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
Rocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 12-Month LowHere's What Happened - MarketBeat
Renaissance Technologies LLC Acquires Shares of 99,574 Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) - MarketBeat
How the (RCKT) price action is used to our Advantage - Stock Traders Daily
A significant driver of top-line growth: Rocket Pharmaceuticals Inc (RCKT) - SETE News
Rocket Pharmaceuticals Inc: Navigating a Turbulent Year, Up -47.36% from 52-Week Low - The InvestChronicle
3.66%
1.11%
大文字化:
|
ボリューム (24 時間):